Eledon Pharmaceuticals (ELDN) Net Income towards Common Stockholders Growth (3y) (2016 - 2026)
Eledon Pharmaceuticals (ELDN) Net Income towards Common Stockholders Growth (3y) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
814,307.08 Bn |
814,307.05 Bn |
- |
- |
| 2 |
Belite Bio |
55,320.00 Bn |
55,320.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
17,149.72 Bn |
17,149.72 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,590.00 Bn |
3,589.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Akari Therapeutics |
1,650.72 Bn |
1,650.72 Bn |
- |
-46.86% |
| 6 |
Evaxion A |
1,522.09 Bn |
1,522.07 Bn |
- |
34.98% |
| 7 |
Psyence Biomedical |
229.39 Bn |
229.38 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.09 Bn |
105.85 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
90.15 Bn |
90.15 Bn |
- |
- |
| 10 |
Eledon Pharmaceuticals |
401.35 Mn |
185.32 Mn |
- |
-49.25% |
| Date | Value |
|---|
| Mar 31, 2026 |
-49.25% |
| Dec 31, 2025 |
44.77% |
| Sep 30, 2025 |
-15.49% |
| Jun 30, 2025 |
-3.87% |
| Mar 31, 2025 |
15.27% |
| Dec 31, 2024 |
-9.07% |
| Sep 30, 2024 |
-16.95% |
| Jun 30, 2024 |
-74.20% |
| Mar 31, 2024 |
-31.88% |
| Dec 31, 2023 |
48.27% |
| Sep 30, 2023 |
-22.15% |
| Jun 30, 2023 |
-58.79% |
| Mar 31, 2023 |
-10.76% |
| Dec 31, 2022 |
-141.08% |
| Sep 30, 2022 |
-53.06% |
| Jun 30, 2022 |
-31.26% |
| Mar 31, 2022 |
-26.48% |
| Dec 31, 2021 |
101.42% |
| Sep 30, 2021 |
-41.04% |
| Jun 30, 2021 |
-32.30% |
